Status:

TERMINATED

Secondary Versus Tertiary Wound Closure in High Risk Gynecologic Abdominal Surgical Incisions

Lead Sponsor:

Wake Forest University Health Sciences

Collaborating Sponsors:

National Cancer Institute (NCI)

Conditions:

Surgical Incision

Eligibility:

FEMALE

18-65 years

Phase:

NA

Brief Summary

The purpose of this research study is to determine if closing a surgical wound differently is better than the procedure that is currently used. The wound will be closed with what is considered "tertia...

Detailed Description

Primary Objective To compare the percentage of patients whose wound remained closed on postoperative day #30 after tertiary closure compared to historical controls who underwent secondary would closu...

Eligibility Criteria

Inclusion

  • Patients with high risk class II, class III, class IV abdominal wounds
  • Undergoing laparotomy for gynecologic related disorders
  • Patients undergoing laparotomy for both benign and malignant diagnoses will be included in this study

Exclusion

  • Pregnancy
  • Allergy to triclosan
  • Patients undergoing HIPEC

Key Trial Info

Start Date :

February 27 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 26 2020

Estimated Enrollment :

8 Patients enrolled

Trial Details

Trial ID

NCT03861065

Start Date

February 27 2019

End Date

November 26 2020

Last Update

July 3 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Comprehensive Cancer Center of Wake Forest University

Winston-Salem, North Carolina, United States, 27157